HomeBREAKING NEWS 2-DG: Granules India Gets Licence from DRDO to Manufacture and Market Covid Drug September 2, 2021 Share Facebook Twitter Pinterest WhatsApp Developed by DRDO, 2-DG has been granted permission by DCGI for emergency use as adjunct therapy in moderate to severe COVID-19 patients. Previous articlePunjab to Let People Visiting Abroad Urgently Take Covishield Second Dose Before 84 DaysNext article3 Pairs of Trains on Rajasthan-West Bengal-Maharashtra Route to Get Extra Coaches Similar Articles Lakhimpur Kheri: Viral Video Shows Farmers Being Run Over by SUV, Oppn Questions Union Minister’s Claims BREAKING NEWS - October 5, 2021 The 29-second clip, which also shows another vehicle following the SUV, has raised questions on the version of the incident by Union minister Ajay... Karnataka: 3 Dead After Drinking Contaminated Water, 108 Show Similar Symptoms BREAKING NEWS - October 5, 2021 A total of six people have died in the last five weeks but the authorities have been able link just three of the deaths... Most Popular AMPC reforms: BJP digs out Siddaramaiah’s old letter India UAE Grow Bilateral Trade Amidst Worldwide Geopolitical Shifts Author Amish on why Bollywood doesn’t adapt ancient Sanskritic texts into films